Stifel Downgrades CONMED (CNMD) to Hold
Tweet Send to a Friend
Stifel analyst Rick Wise downgraded CONMED (NYSE: CNMD) from Buy to Hold with a price target of $55.00 (from $75.00).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


